von Achenbach, Caroline; Hevia Hernandez, Giselle; von Gunten, Stephan (2022). The Choice between Intravenous and Subcutaneous Immunoglobulins: Aspects for Consideration. Pharmacology, 107(11-12), pp. 556-563. Karger 10.1159/000527655
![[img]](https://boris.unibe.ch/style/images/fileicons/text.png) |
Text
Achenbach.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (437kB) | Request a copy |
BACKGROUND
Intravenous immunoglobulin and subcutaneous immunoglobulin preparations are used to treat primary and secondary immunodeficiencies, as well as autoimmune and inflammatory conditions.
SUMMARY
For certain indications, only defined formulations or routes of administration are approved by health authorities. However, for other diseases, there are more options, and treatment decisions may be based on different aspects, such as patient conditions and preferences, pharmacokinetics, or pharmacoeconomic considerations.
KEY MESSAGES
Understanding the two different treatment modalities may support the decision-making for the optimal therapeutic option for individual patients. This review summarizes the latest insights into the direct and indirect comparison between the two types of products.
Item Type: |
Journal Article (Review Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Pharmacology |
UniBE Contributor: |
Hevia Hernandez, Giselle, von Gunten, Stephan |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
0031-7012 |
Publisher: |
Karger |
Language: |
English |
Submitter: |
Pubmed Import |
Date Deposited: |
10 Nov 2022 13:56 |
Last Modified: |
06 Dec 2022 00:16 |
Publisher DOI: |
10.1159/000527655 |
PubMed ID: |
36349790 |
Uncontrolled Keywords: |
Autoimmunity Immunodeficiency Intravenous immunoglobulin Subcutaneous immunoglobulin |
BORIS DOI: |
10.48350/174631 |
URI: |
https://boris.unibe.ch/id/eprint/174631 |
Actions (login required)
 |
Edit item |